期刊文献+

李可乌蛇荣皮汤合攻毒散治疗寻常型银屑病30例疗效观察 被引量:2

下载PDF
导出
摘要 目的:观察李可乌蛇荣皮汤合攻毒散治疗寻常型银屑病的疗效。方法:将60例患者随机分为2组各30例,治疗组采用李可乌蛇荣皮汤水煎口服,同时外用攻毒散;对照组以攻毒散外用治疗。1月为1疗程,疗程结束后评定疗效。结果:总有效率治疗组为93.3%,对照组为76.7%,2组比较,差异有显著意义(P<0.05)。治疗1周,皮损全部消失患者治疗组有11例,对照组有3例,2组比较,差异有显著性意义(P<0.05)。随访半年,复发率治疗组为7.0%,对照组为39.1%,2组比较,差异有显著性意义(P<0.05)。皮肤色素遗留率治疗组为14.3%,对照组为47.8%,2组比较,差异有显著性意义(P<0.05)。结论:乌蛇荣皮汤合攻毒散治疗银屑病疗效确切,起效快,复发率低。
作者 吉贤
出处 《新中医》 CAS 2014年第11期149-151,共3页 New Chinese Medicine
  • 相关文献

参考文献4

  • 1张学军.皮肤性病学[M].5版,北京:人民卫生出版社,2002:183
  • 2李曰庆.中医外科学[M].2版.北京:人民卫生出版社,2011:184.
  • 3李可,主编.李可老中医急危重症疑难病经验专辑[M].太原:山西科学技术出版社,2002:6
  • 4李先平,李晶,王皓,郭亚军.银屑病生物治疗研究进展[J].中国医药生物技术,2007,2(3):207-211. 被引量:8

二级参考文献19

  • 1[1]Luba KM,Stulberg DL.Chronic plaque psoriasis.Am Fam Physician,2006,73(4):636-644.
  • 2[4]Krueger JG.The immunologic basis for the treatment of psoriasis with new biologic agents.J Am Acad Dermatal,2002,46(1):1-23.
  • 3[5]Cball LA,Tso JY,Melrose J,et al.HuM291(Nuvion),a humanized Fc receptor-nonbinding antibody against CD3,anergizes peripheral blood T cells as partial agonist of the T cell receptor.Transplantation,2001,71(7):941-950.
  • 4[6]Skov L,Kragballe K,Zachariae C,et al.HuMax-CD4:a fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris.Arch Dermatol,2003,139(11):1433-1439.
  • 5[7]Bachelez H,Flageul B,Dubertret L,et al.Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4.J Autoimmun,1998,11(1):53-62.
  • 6[8]Gottlieb AB,Krueger JG,Wittkowski K,et al.Psoriasis as a model for T-cell-mediated disease:immunobiologic and clinical affects of treatment with multiple doses of efalizumab,an anti-CD11a antibody.Arch Dermatol,2002,1381(5):591-600.
  • 7[9]Krueger JG,Waiters IB,Miyazawa M,et al.Successful in vivo blockade of CD25(high-affinity interleukin 2 receptor)on T cells by administration of humanized anti-Tac antibody to patients with psoriasis.J Am Acad Dermatol,2000,43(3):448-458.
  • 8[10]da Silva AJ,Brickelmaier M,Majeau GR,et al.Alefacept,an immunomodulatory recombinant LFA-3/IgG1 fusion protein,induces CD16 signaling and CD2/CD16-dependent apoptosis of CD2(+)cells.J Immunol,2002,168(9):4462-4471.
  • 9[11]Ellis CN,Krueger GG.Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.N Engl J Med,2001,345(4):248-255.
  • 10[13]Najafian N,Sayegh MH.CTLA4-Ig:a novel immanosuppressive agent.Expert Opin Investig Drugs,2000,9(9):2147-2157.

共引文献124

同被引文献18

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部